Cordyceps Sunshine Biotech Holdings (RAJAF) Debt Ratio (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.1 for Q4 2025.

• In Q4 2025, Debt Ratio rose 3.06% year-over-year to 0.1; the TTM figure through Dec 2025 stood at 0.1 (up 3.06% YoY), while the FY2025 annual figure was 0.1, up 3.06% from the prior year.
• Debt Ratio was 0.1 for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from 0.1 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.61 in Q4 2021 to a low of 0.1 in Q4 2024.
• Historically, Debt Ratio has averaged 0.26 across 5 years, with a median of 0.18 in 2023.
• The sharpest annual moves came in 2023 and 2025: Debt Ratio plunged 67.31% in 2023, then rose 3.06% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.61 in 2021, then sank by 35.34% to 0.39 in 2022, then slumped by 67.31% to 0.13 in 2023, then fell by 24.64% to 0.1 in 2024, then rose by 3.06% to 0.1 in 2025.
• The last three Debt Ratio figures came in at 0.1 (Q4 2025), 0.1 (Q4 2024), and 0.13 (Q4 2023), per Business Quant data.